Pegasus Peptides Reta 40mg research peptide vial

Reta 40mg

£148.05In Stock

A triple agonist peptide targeting the GLP-1, GIP and glucagon receptors, investigated in metabolic research. Supplied strictly for laboratory research use only — not for human or veterinary use.

Molecular Formula:

C221H342N46O68

Peptide content / vial:

40mg

Format:

Lyophilised powder

1
Total: £148.05

Frequently purchased together

Bacteriostatic Mixing Water 10ml

Bacteriostatic Mixing Water 10ml

£5.99

Commonly purchased alongside research products.

✓ For laboratory research use only

Certificate / COA available upon request.

COA on Request

Research Grade

UK Dispatch

Product Description

Reta 40mg is supplied as a research-grade lyophilised peptide with the molecular formula C221H342N46O68, containing 40mg of peptide per vial, intended strictly for in-vitro laboratory research. Certificates of Analysis and product documentation are available on request.

RTTA 40mg supplied as lyophilised powder for laboratory research use only. Certificates of Analysis and product documentation are available on request.

IMPORTANT: This product is for research purposes only. Not intended for human or veterinary use, consumption or administration.

RESEARCH USE ONLY

Materials are supplied exclusively for legitimate laboratory and scientific research and are not intended for human or veterinary use, diagnosis, treatment or therapeutic application.